Free Trial
OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

MariMed logo
$0.12 +0.01 (+11.43%)
As of 03:56 PM Eastern

About MariMed Stock (OTCMKTS:MRMD)

Key Stats

Today's Range
$0.10
$0.12
50-Day Range
$0.07
$0.11
52-Week Range
$0.07
$0.29
Volume
414,210 shs
Average Volume
381,978 shs
Market Capitalization
$45.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

MRMD Stock News Headlines

Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
MariMed Announces Second Quarter 2025 Earnings Date
See More Headlines

MRMD Stock Analysis - Frequently Asked Questions

MariMed's stock was trading at $0.1158 on January 1st, 2025. Since then, MRMD shares have increased by 0.2% and is now trading at $0.1160.

MariMed Inc. (OTCMKTS:MRMD) released its earnings results on Wednesday, May, 7th. The company reported ($0.01) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.01). The business had revenue of $37.96 million for the quarter, compared to analyst estimates of $38.33 million. MariMed had a negative trailing twelve-month return on equity of 10.21% and a negative net margin of 10.33%.
Read the conference call transcript
.

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MariMed investors own include Canopy Growth (CGC), Innovative Industrial Properties (IIPR), NVIDIA (NVDA), Curaleaf (CURLF), Aurora Cannabis (ACB), Meta Platforms (META) and Tilray Brands (TLRY).

Company Calendar

Last Earnings
5/07/2025
Today
7/25/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MRMD
Previous Symbol
OTC:MRMD
CIK
1522767
Fax
N/A
Employees
260
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.16 million
Net Margins
-10.33%
Pretax Margin
-4.40%
Return on Equity
-10.21%
Return on Assets
-3.12%

Debt

Debt-to-Equity Ratio
1.21
Current Ratio
1.05
Quick Ratio
0.37

Sales & Book Value

Annual Sales
$157.96 million
Price / Sales
0.28
Cash Flow
$0.02 per share
Price / Cash Flow
4.77
Book Value
$0.16 per share
Price / Book
0.71

Miscellaneous

Outstanding Shares
390,435,000
Free Float
316,291,000
Market Cap
$44.43 million
Optionable
Not Optionable
Beta
2.90
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (OTCMKTS:MRMD) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners